ePurines, Inc.

SALT LAKE CITY, UT · Founded 2017 · CIK 0001828526 · Biotech · Private

Purinergic receptor-targeted small molecule therapeutics for metabolic and organ diseases

epurines.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$50K
1 Form D · Oct 2020
72 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$50,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2666Amicus Inc. / DE—$50K
2667Scudo Biosciences Inc—$50K
2668Orna Therapeutics——
2669ePurines, Inc.—$50K
2670AFFINITY MOLECULES LLC——
2671Paralos Bioscience Inc.—$50K
2672POTOMAC AFFINITY PROTEIN LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Karen DwyerDirector
  • Bellamkonda KishoreExecutive Officer
  • Christa MullerDirector
  • Janso Peti-PeterdiDirector
  • Simon RobsonDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.